Type 1 Diabetes Extension Study
Summary
- Eligibility
- for people ages 8-35 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Stephen Gitelman
Description
Summary
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Stephen Gitelman
I am involved in a variety of different translational and clinical research projects, most related to diabetes. A number of the on-going studies are attempts to alter the course of autoimmune-mediated type 1 diabetes, often via immunomodulation, in order to preserve endogenous beta cell function. Some of the recent and on-going projects are described below.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Links
- National Institute of Allergy and Infectious Diseases (NIAID) Division of Allergy, Immunology, and Transplantation (DAIT) ITN T1D Extended Study (T1DES) website
- ID
- NCT02734277
- Study Type
- Observational
- Last Updated